Skip to main content
. 2012 Jan 17;30(6):2352–2363. doi: 10.1007/s10637-011-9789-z

Fig. 1.

Fig. 1

Mean (SD) plasma concentration–time profiles of dacomitinib following single (panel a; D-9) and multiple (panel b; C1D14) dosing